A bayesian strategy for screening cancer treatments prior to phase ii clinical evaluation

Peter F. Thall, Elihu H. Estey

Type: Article

Publication Date: 1993-01-01

Citations: 43

DOI: https://doi.org/10.1002/sim.4780121303

View Publication

Locations

PubMed - View
Statistics in Medicine - View

Similar Works

Action	Title	Year	Authors
+ PDF Chat	Bayesian Optimal Design for Phase II Screening Trials	2007	Meichun Ding Gary L. Rosner Peter Müller
+	A Bayesian approach to the design of phase II clinical trials	1991	Richard Sylvester
+	Bayesian approach to two-stage phase trial	1997	Patricia A. Pepple Sung C. Choi
+	A bayesian approach to sample size determination in phase II cancer clinical trials	1984	Richard Sylvester
+	Practical Bayesian Guidelines for Phase IIB Clinical Trials	1994	Peter F. Thall Richard H. Simon
+	Bayesian Methods for Cancer Phase I Clinical Trials	2003	André Rogatko James S. Babb
+	Bayesian Methods for Cancer Phase I Clinical Trials	2003	James S. Babb and Andre ́ Rogatko
+ PDF Chat	Bayesian adaptive phase II screening design for combination trials	2013	Chunyan Cai Ying Yuan Valen E. Johnson
+	A Bayesian approach to establishang sample size and monitoring criteria for phase II clinical trials	1994	Peter F. Thall Richard Simon
+	Bayesian procedures for phase I/II clinical trials investigating the safety and efficacy of drug combinations	2011	John Whitehead Helene Thygesen Anne Whitehead
+	Bayesian Designs for Phase I–II Clinical Trials	2017	Ying Yuan Hoang Q. Nguyen Peter F. Thall
+	Bayesian analysis of phase I clinical trials	1990	Joel B. Greenhouse Constantine Gatsonis
+	Phase II clinical trials - Bayesian methods	2018	Fei Ye
+	A Bayesian predictive strategy for an adaptive two‐stage design in phase II clinical trials	2010	Valeria Sambucini
+	A Bayesian Approach to the Design of Phase II Clinical Trials	1988	Richard Sylvester
+	Design Issues of Randomized Phase II Trials and a Proposal for Phase II Screening Trials	2005	Larry Rubinstein Edward L. Korn Boris Freidlin Sally Hunsberger S. Percy Ivy Malcolm A. Smith
+	Optimal sample sizes for phase II clinical trials and pilot studies	2011	Nigel Stallard
+ PDF Chat	Bayesian design and conduct of phase II single-arm clinical trials with binary outcomes: A tutorial	2007	Sarah Zohar Satoshi Teramukai Yinghui Zhou
+	A randomized two‐stage design for phase II clinical trials based on a Bayesian predictive approach	2014	Matteo Cellamare Valeria Sambucini
+ PDF Chat	MIDAS: a practical Bayesian design for platform trials with molecularly targeted agents	2016	Ying Yuan Beibei Guo Mark F. Munsell Karen H. Lu Amir A. Jazaeri

Works That Cite This (28)

Action	Title	Year	Authors
+ PDF Chat	Bayesian statistics in medicine: a 25 year review	2006	Deborah Ashby
+	Bayesian clinical trials at The University of Texas MD Anderson Cancer Center: An update	2019	Rebecca S.S. Tidwell S. Andrew Peng Minxing Chen Diane D. Liu Ying Yuan J. Jack Lee
+ PDF Chat	A 25‐year review of sequential methodology in clinical studies	2006	Susan Todd
+ PDF Chat	Bayesian design and conduct of phase II single-arm clinical trials with binary outcomes: A tutorial	2007	Sarah Zohar Satoshi Teramukai Yinghui Zhou
+ PDF Chat	Stopping rules for phase II studies	2001	Nigel Stallard John Whitehead Susan Todd Anne Whitehead
+	New designs for phase 2 clinical trials	2003	Elihu H. Estey Peter F. Thall
+	Optimal Sample Size for a Series of Pilot Trials of New Agents	1996	Tzy‐Jyun Yao Colin B. Begg Philip O. Livingston
+	Decision-Theoretic Designs for Pre-Phase II Screening Trials in Oncology	2001	Nigel Stallard Peter F. Thall
+	A Bayesian predictive strategy for an adaptive two‐stage design in phase II clinical trials	2010	Valeria Sambucini
+ PDF Chat	A Bayesian adaptive phase II clinical trial design accounting for spatial variation	2018	Beibei Guo Yong Zang

Works Cited by This (13)

Action	Title	Year	Authors
+	Parametric Empirical Bayes Inference: Theory and Applications	1983	Carl N. Morris
+	The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent	1961	Edmund A. Gehan
+ PDF Chat	Randomization in clinical trials: Conclusions and recommendations	1988	John M. Lachin John P. Matts L. J. Wei
+	Selecting the best binomial population: parametric empirical Bayes approach	1989	Shanti S. Gupta TaChen Liang
+	Two-stage selection and testing designs for comparative clinical trials	1988	Peter F. Thall Richard Simon Susan S. Ellenberg
+ PDF Chat	Properties of the urn randomization in clinical trials	1988	L. J. Wei John M. Lachin
+	Interim Analysis in Clinical Trials: The Role of the Likelihood Principle	1987	Donald A. Berry
+	A Two-Stage Design for Choosing among Several Experimental Treatments and a Control in Clinical Trials	1989	Peter F. Thall Richard Simon Susan S. Ellenberg
+	Sample sizes for phase II and phase III clinical trials: An integrated approach	1986	John Whitehead
+	Interim analyses in clinical trials: Classical vs. bayesian approaches	1985	Donald A. Berry